Product Information
FLUVASTATIN SODIUM 20 MG CAP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $2.6729 per EA under NDC 00378802077. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378802077
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUVASTATIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA090595FDA Approved
4/11/2012
TE Code
AB
On Market Since
3/19/2013
Pharmacological Classes
Price Statistics
The NADAC for FLUVASTATIN SODIUM 20 MG CAP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6729 per EA |
|---|---|
| All-time high | $4.2307 (Apr 13, 2016) |
| All-time low | $2.6729 (Sep 23, 2026) |
| 52-week high | $3.2094 |
| 52-week low | $2.6729 |
| Median price | $3.5696 |
| Average price | $3.5006 |
| Largest weekly change | +17.1% (Jun 25, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUVASTATIN SODIUM 20 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for FLUVASTATIN SODIUM 20 MG CAP, manufactured by Mylan Pharmaceuticals Inc., is $2.6729 per EA (NDC 00378802077), effective Sep 30, 2026.
How has the price of FLUVASTATIN SODIUM 20 MG CAP changed over time?
Over the history we have for it, the NADAC for FLUVASTATIN SODIUM 20 MG CAP has declined 16.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUVASTATIN SODIUM 20 MG CAP?
Since Nov 28, 2013, the NADAC for FLUVASTATIN SODIUM 20 MG CAP has ranged from a low of $2.6729 (Sep 23, 2026) to a high of $4.2307 (Apr 13, 2016), with a median of $3.5696 per EA.
Are there cheaper alternatives to FLUVASTATIN SODIUM 20 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLUVASTATIN SODIUM 20 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUVASTATIN SODIUM 20 MG CAP?
FLUVASTATIN SODIUM 20 MG CAP (NDC 00378802077) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.